Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine
Description
CONCLUSIONS: The 2023-2024 formula COVID-19 vaccine given to working-aged adults afforded modest protection overall against COVID-19 before the JN.1 lineage became dominant, and less protection after.
